Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our medicines are helping millions of people around the world in their fight against cancer, cardiovascular disease, hepatitis C, HIV and rheumatoid arthritis.
Booth number: B01
For 125 years, MSD has been a global health care leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., Kenilworth, N.J., USA. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
Booth number: B09
F. Hoffmann-La Roche Ltd.
Since 1896, Roche has been a global pioneer in advancing science to improve people’s lives. Today we are leaders in truly differentiated medicines (in oncology, immunology and more) and diagnostics (in vitro diagnostics, tissue-based cancer diagnostics and more). We also lead and partner in personalised healthcare – a strategy to identify the right treatment for the right patient at the right time.
Booth number: A09
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Booth number: C09
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Booth number: E01
Astellas Pharma Singapore Pte. Ltd.
Astellas is a Tokyo based pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals.
Booth number: D01
Boehringer Ingelheim is committed to delivering novel anti-cancer agents that address unmet needs across a broad range of solid and haematological malignancies. For lung cancer BI now has two agents approved in a number of markets for specific NSCLC sub-types. The late stage portfolio is supported by a strong early pipeline.
Booth number: C01
For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world.
Booth number: D09
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, alongside helping patients with infertility, endocrine and metabolic disorders as well as cardiovascular diseases, to cutting-edge systems for scientific research and production, and furthermore liquid crystals for smartphones and LCD televisions. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Booth number: A17
At Pfizer Singapore, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care in Singapore.
Booth number: E09
AbbVie Pte Ltd.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.
Booth number: F12
ACT Genomics is a leading integrated cancer profiling service provider in Asia. We bring services to transform treatment paradigm, enhance treatment solution for targeted therapy and immunotherapy, monitor changes in tumour, and support precision oncology drug development in the CAP-accredited environment. Together, we turn genomics into action.
Booth number: G08
Biocartis aims to provide direct access to personalised medicine for patients worldwide by developing fully integrated, broadly applicable molecular diagnostics. Biocartis’ MDx Idylla™ platform is a fully automated sample-to-result, real-time Polymerase Chain Reaction system that offers accurate, highly reliable molecular information from virtually any biological sample in virtually any setting.
Booth number: G05
Cancer Expert Now
Cancer Expert Now helps cancer patients and their doctors achieve optimal treatment by providing fast, customised information about their cancer management from top cancer experts. Our growing network of cancer experts utilise a secure platform to provide doctor-to-doctor collaboration via video chat and messaging and host "Expert Point of View" videos focusing on hot topics in cancer research and treatment.
Booth number: G04
Eisai Co., Ltd.
Eisai Co., Ltd. is a leading pharmaceutical company headquartered in Japan. We define our corporate mission as “giving first thought to patients and their families and to increasing the benefits health care provides", ie. our “human health care (hhc)” philosophy. We strive to realise our philosophy especially focusing on Oncology. Eisai currently has footprints in approximately 65 locations globally.
Booth number: F01
Human Longevity, Inc.
Revolutionising Healthcare - Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company leading the way to fully integrate personalised and preventative care into the practice of medicine. HLI has built one of the world’s largest and most comprehensive databases of whole genome, phenotype and clinical data. HLI is applying large-scale computing and machine learning to make novel discoveries to revolutionise healthcare. HLI’s business also includes the HLI Health Nucleus, a genomic powered clinical research centre which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health.
Booth number: F16
Human Metabolome Technologies
HMT provides high-sophisticated metabolome analysis service packages based on the unique measurement system, CE-MS (Capillary Electrophoresis Mass Spectrometry), which covers more than 900 hydrophilic metabolites. We have experienced analysis of various types of samples such as cultured cells, animal tissues, blood, sliver, urine, faeces, microbes, plants, food ingredients, etc. Let’s open the new door to next stage with metabolomics.
Booth number: F14
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. At Sanofi, we are committed to contribute to the continuous advancement of health, and we have always striven to advance the cause of health by developing treatments that prevent and treat diseases, while enhancing access to healthcare for the people around the world.
Booth number: F18
Sysmex Asia Pacific
Sysmex Asia Pacific Pte Ltd is a subsidiary of Sysmex Corporation of Japan. Sysmex delivers total solutions in the field of clinical laboratory testing and molecular diagnostics. In the exciting world of molecular diagnostics, Sysmex’s new product OncoBeamTM technology is one of the most sensitive technologies available today for the detection of tumour specific somatic mutations in blood samples, Our highly sensitive OncoBEAM™ assays detect gene mutations in cancer allowing for more targeted therapies and monitoring of disease response and recurrence to identify clinically actionable tumour specific somatic mutations in blood samples.
Booth number: F13
Xi’an Good Doctor Medical Science and Technology Co.,Ltd.
G&D Company is the leading supplier of the HIPEC system. Innovation of G&D HI PEC is minimally invasive and can be used in pre-, intra-, and post-cytoreductive surgery. G&D HIPEC can be applied repetitively not only in the treatment of ascites, but also malignant pleural effusion. G&D HIPEC is superior to conventional method in the treatment of malignant effusion and carcinometosis.
Booth number: F15
Educational Grant Sponsor
Pierre Fabre, the 2nd largest private pharmaceutical group in France, is headquartered in the South-West of France and operates directly in 43 countries worldwide. Its portfolio represents a continuum ranging from speciality pharmaceuticals to dermo-cosmetic products. In particular, Pierre Fabre's know-how in oncology is based on three decades of experience in the discovery, development and global commercialisation of innovative cancer drugs such as monoclonal antibodies and natural cytotoxic agents.